Pioneering discovery science
Discovery science is the foundation beneath every bold and lifesaving innovation in cancer care. MSK researchers are devising previously unimaginable strategies to detect and treat the disease, catapulting cancer research into a future where technology will break down the final boundaries in oncology.
Understanding cancer at every level
The Sloan Kettering Institute (SKI) is the dedicated research arm of MSK, where scientific experts are leading investigations across nine program areas to learn everything we possibly can about cancer. Discoveries made by SKI scientists over the years have represented some of the biggest milestones in cancer history.
So we can identify new targets for treatment
In 2024 alone, the FDA approved 11 drugs based on significant contributions by MSK investigators — progress that will continue thanks to the MSK Giving community. As a donor, you are an essential source of support for researchers as they break more barriers, find new treatments, and explore new ways to use existing drugs to save lives.
At MSK, researchers study cancer’s entire ecosystem to develop better treatments.
Learn how research advances progress
See how your gift can propel new discoveries in cancer
Researching tumor behavior
Embedded in the Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center, the Single-Cell Analytics Innovation Lab provides unparalleled insights into cancer-related questions regarding immunity, tumor metastasis, and regeneration.
Learn moreVisualizing cancer cells
The Center for Molecular Imaging and Bioengineering integrates novel molecular imaging methods and state-of-the-art bioengineering tools to revolutionize the way MSK approaches cancer research.
See how they do itUnderstanding heterogeneity
Cancer biologist Tuomas Tammela studies how cancer cells within lung and pancreatic tumors can be so different from each other.
Visit his labUsing AI to study cancer
Computational biologist Quaid Morris, PhD, uses artificial intelligence techniques and develops machine learning algorithms to study gene regulation, cancer evolution, clinical informatics, and other topics in systems biology.
Learn about his workHelp us tackle the biggest questions in cancer
The MSK Campaign: Leading Science. Changing Lives.
The MSK community is raising $6 billion by 2030 to accelerate advances across six key strategic initiatives. Learn more and join us in our mission of ending cancer for life.
Learn more about The MSK Campaign